Table of Contents
Journal of Quantum Chemistry
Volume 2014 (2014), Article ID 431432, 15 pages
http://dx.doi.org/10.1155/2014/431432
Research Article

A Theoretical Study of the Relationships between Electronic Structure and CB1 and CB2 Cannabinoid Receptor Binding Affinity in a Group of 1-Aryl-5-(1-H-pyrrol-1-yl)-1-H-pyrazole-3-carboxamides

Quantum Pharmacology Unit, Department of Chemistry, Faculty of Sciences, University of Chile, Las Palmeras 3425, Nuñoa, 7800003 Santiago, Chile

Received 31 July 2013; Revised 22 September 2013; Accepted 23 September 2013; Published 2 January 2014

Academic Editor: Daniel Glossman-Mitnik

Copyright © 2014 Francisco Salgado-Valdés and Juan S. Gómez-Jeria. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. L. Abel, Marihuana, the First Twelve Thousand Years, McGraw-Hill, New York, NY, USA, 1982.
  2. H.-L. Li, “An archaeological and historical account of Cannabis in China,” Economic Botany, vol. 28, no. 4, pp. 437–448, 1973. View at Publisher · View at Google Scholar · View at Scopus
  3. M. L. Ryder, “Probable fibres from hemp (Cannabis sativa L.) in bronze age Scotland,” Environmental Archaeology, vol. 4, no. 1, pp. 93–95, 1999. View at Google Scholar
  4. C. Sherman, A. Smith, and E. Tanner, Highlights: An Illustrated History of Cannabis, Ten Speed Press, Berkeley, Calif, USA, 1999.
  5. J. P. Mallory and V. H. Mair, The Tarim Mummies: Ancient China and the Mystery of the Earliest Peoples from the West, with 190 illustrations, 13 in color, Thames & Hudson, New York, NY, USA, 2000.
  6. M. Booth, Cannabis: A History, Picador, New York, NY, USA, 2005.
  7. C. Bennett, Cannabis and the Soma Solution, TrineDay, Waterville, Ore, USA, 2010.
  8. H.-E. Jiang, X. Li, Y.-X. Zhao et al., “A new insight into Cannabis sativa (Cannabaceae) utilization from 2500-year-old Yanghai Tombs, Xinjiang, China,” Journal of Ethnopharmacology, vol. 108, no. 3, pp. 414–422, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Emboden, “Cannabis—a polytypic genus,” Economic Botany, vol. 28, no. 3, pp. 304–310, 1974. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Small, H. D. Beckstead, and A. Chan, “The evolution of cannabinoid phenotypes in Cannabis,” Economic Botany, vol. 29, no. 3, pp. 219–232, 1975. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Small and A. Cronquist, “A practical and natural taxonomy for Cannabis,” Taxon, vol. 25, no. 4, pp. 405–435, 1976. View at Google Scholar
  12. E. Small, P. Y. Jui, and L. P. Lefkovitch, “A numerical taxonomic analysis of Cannabis with special reference to species delimitation,” Systematic Botany, vol. 1, no. 1, pp. 67–84, 1976. View at Google Scholar
  13. S. L. Datwyler and G. D. Weiblen, “Genetic variation in hemp and marijuana (Cannabis sativa L.) according to amplified fragment length polymorphisms,” Journal of Forensic Sciences, vol. 51, no. 2, pp. 371–375, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Chandra, H. Lata, A. M. Galal, I. A. Khan, and M. A. ElSohly, “Botany of Cannabis sativa L.: identification, cultivation and processing,” Planta Medica, vol. 77, no. 5, article P_4, 2011. View at Publisher · View at Google Scholar
  15. H. van Bakel, J. Stout, A. Cote et al., “The draft genome and transcriptome of Cannabis sativa,” Genome Biology, vol. 12, no. 10, article R102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. H. Mills, Madness, Cannabis and Colonialism: The “Native Only” Lunatic Asylums of British India, 1857–1900, St. Martin's Press, New York, NY, USA, 2000.
  17. J. H. Mills, Cannabis Britannica: Empire, Trade, and Prohibition, 1800–1928, Oxford University Press, Oxford, UK, 2003.
  18. J. H. Mills and P. Barton, Drugs and Empires: Essays in Modern Imperialism and Intoxication, c.1500–c.1930, Palgrave Macmillan, Basingstoke, UK, 2007.
  19. J. S. Gómez-Jeria, F. Soto-Morales, and G. Larenas-Gutierrez, “A zindo/1 study of the cannabinoid-mediated inhibition of adenylyl cyclase,” Iranian International Journal of Science, vol. 4, no. 2, pp. 151–164, 2003. View at Google Scholar
  20. J. S. Gómez-Jeria, F. Soto-Morales, J. Rivas, and A. Sotomayor, “A theoretical structure-affinity relationship study of some cannabinoid derivatives,” Journal of the Chilean Chemical Society, vol. 53, no. 1, pp. 1382–1388, 2008. View at Google Scholar · View at Scopus
  21. C. Hale, Himmler's Crusade: The Nazi Expedition to Find the Origins of the Aryan Race, John Wiley & Sons, Hoboken, NJ, USA, 2003.
  22. R. G. Pertwee, “Cannabinoid pharmacology: the first 66 years,” British Journal of Pharmacology, vol. 147, supplement 1, pp. S163–S171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. R. G. Pertwee, A. C. Howlett, M. E. Abood et al., “International union of basic and clinical pharmacology. LXXIX: cannabinoid receptors and their ligands: beyond CB1 and CB2,” Pharmacological Reviews, vol. 62, no. 4, pp. 588–631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Console-Bram, J. Marcu, and M. E. Abood, “Cannabinoid receptors: nomenclature and pharmacological principles,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 38, no. 1, pp. 4–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Battista, M. di Tommaso, M. Bari, and M. Maccarrone, “The endocannabinoid system: an overview,” Frontiers in Behavioral Neuroscience, vol. 6, article 9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Pamplona and R. Takahashi, “Psychopharmacology of the endocannabinoids: far beyond anandamide,” Journal of Psychopharmacology, vol. 26, no. 1, pp. 7–22, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Mechoulam and L. A. Parker, “The endocannabinoid system and the brain,” Annual Review of Psychology, vol. 64, no. 1, pp. 21–47, 2013. View at Google Scholar
  28. E. J. van Bockstaele, “Endocannabinoids and monoamines: modulating the modulators,” in Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders, E. J. van Bockstaele, Ed., pp. 1–9, Springer, New York, NY, USA, 2013. View at Google Scholar
  29. R. A. Archer, D. B. Boyd, P. V. Demarco, I. J. Tyminski, and N. L. Allinger, “Structural studies of cannabinoids. Theoretical and proton magnetic resonance analysis,” Journal of the American Chemical Society, vol. 92, no. 17, pp. 5200–5206, 1970. View at Google Scholar · View at Scopus
  30. E. A. Carlini, M. Santos, U. Claussen, D. Bieniek, and F. Korte, “Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semi-purified extracts of Cannabis sativa,” Psychopharmacologia, vol. 18, no. 1, pp. 82–93, 1970. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Edery, Y. Grunfeld, Z. Ben-Zvi, and R. Mechoulam, “Structural requirements for cannabinoid activity,” Annals of the New York Academy of Sciences, vol. 191, no. 1, pp. 40–53, 1971. View at Google Scholar
  32. B. Loev, P. E. Bender, F. Dowalo, E. Macko, and P. J. Fowler, “Cannabinoids. Structure-activity studies related to 1,2-dimethylheptyl derivatives,” Journal of Medicinal Chemistry, vol. 16, no. 11, pp. 1200–1206, 1973. View at Google Scholar · View at Scopus
  33. D. B. Uliss, H. C. Dalzell, G. R. Handrick, J. F. Howes, and R. K. Razdan, “Hashish. Importance of the phenolic hydroxyl group in tetrahydrocannabinols,” Journal of Medicinal Chemistry, vol. 18, no. 2, pp. 213–215, 1975. View at Publisher · View at Google Scholar · View at Scopus
  34. P. F. Osgood, J. F. Howes, R. K. Razdan, and H. G. Pars, “Drugs derived from cannabinoids. 7: tachycardia and analgesia structure-activity relationships in Δ9-tetrahydrocannabinol and some synthetic analogues,” Journal of Medicinal Chemistry, vol. 21, no. 8, pp. 809–811, 1978. View at Google Scholar · View at Scopus
  35. S. H. Smith, L. S. Harris, I. M. Uwaydah, and A. E. Munson, “Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity,” Journal of Pharmacology and Experimental Therapeutics, vol. 207, no. 1, pp. 165–170, 1978. View at Google Scholar · View at Scopus
  36. T. Cordova, D. Ayalon, N. Lander et al., “The ovulation blocking effect of cannabinoids: structure-activity relationships,” Psychoneuroendocrinology, vol. 5, no. 1, pp. 53–62, 1980. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Tamir, R. Mechoulam, and A. Y. Meyer, “Cannabidiol and phenytoin: a structural comparison,” Journal of Medicinal Chemistry, vol. 23, no. 2, pp. 220–223, 1980. View at Google Scholar · View at Scopus
  38. F. Hucho, Neuroreceptors: Proceedings of the Symposium, Berlin (West), September 28-29, 1981, Walter de Gruyter, Berlin, Germany, 1981.
  39. B. R. Martin, M. J. Kallman, G. F. Kaempf, L. S. Harris, W. L. Dewey, and R. K. Razdan, “Pharmacological potency of R- and S-3′-hydroxy-Δ9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity,” Pharmacology Biochemistry and Behavior, vol. 21, no. 1, pp. 61–65, 1984. View at Google Scholar · View at Scopus
  40. R. K. Razdan, “Structure-activity relationships in cannabinoids,” Pharmacological Reviews, vol. 38, no. 2, pp. 75–149, 1986. View at Google Scholar · View at Scopus
  41. R. S. Rapaka and A. Makriyannis, Structure-Activity Relationships of the Cannabinoids, U.S. Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, Rockville, Md, USA, 1987.
  42. R. Silvestri, A. Ligresti, G. L. Regina et al., “Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile,” Bioorganic & Medicinal Chemistry, vol. 17, no. 15, pp. 5549–5564, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. J. S. Gomez Jeria, “La pharmacologie quantique,” Bollettino Chimico Farmaceutico, vol. 121, no. 12, pp. 619–625, 1982. View at Google Scholar · View at Scopus
  44. J. S. Gómez-Jeria, “On some problems in quantum pharmacology I. The partition functions,” International Journal of Quantum Chemistry, vol. 23, no. 6, pp. 1969–1972, 1983. View at Google Scholar
  45. J. S. Gómez-Jeria, “Modeling the drug-receptor interaction in quantum pharmacology,” in Molecules in Physics, Chemistry, and Biology, J. Maruani, Ed., vol. 4, pp. 215–231, Springer, Amsterdam, The Netherlands, 1989. View at Google Scholar
  46. J. S. Gómez-Jeria, “A new set of local reactivity indices within the Hartree-Fock-Roothaan and density functional theory frameworks,” Canadian Chemical Transactions, vol. 1, no. 1, pp. 25–55, 2013. View at Google Scholar
  47. J. S. Gómez-Jeria and D. R. Morales-Lagos, “Quantum chemical approach to the relationship between molecular structure and serotonin receptor binding affinity,” Journal of Pharmaceutical Sciences, vol. 73, no. 12, pp. 1725–1728, 1984. View at Google Scholar · View at Scopus
  48. J. S. Gómez-Jeria, D. Morales-Lagos, J. I. Rodriguez-Gatica, and J. C. Saavedra-Aguilar, “Quantum-chemical study of the relation between electronic structure and pA2 in a series of 5-substituted tryptamines,” International Journal of Quantum Chemistry, vol. 28, no. 4, pp. 421–428, 1985. View at Google Scholar
  49. J. S. Gómez-Jeria, D. Morales-Lagos, B. K. Cassels, and J. C. Saavedra-Aguilar, “Electronic structure and serotonin receptor binding affinity of 7-substituted tryptamines QSAR of 7-substituted tryptamines,” Quantitative Structure-Activity Relationships, vol. 5, no. 4, pp. 153–157, 1986. View at Google Scholar · View at Scopus
  50. J. S. Gómez-Jeria and P. Sotomayor, “Quantum chemical study of electronic structure and receptor binding in opiates,” Journal of Molecular Structure, vol. 166, pp. 493–498, 1988. View at Google Scholar · View at Scopus
  51. J. S. Gómez-Jeria, M. Ojeda-Vergara, and C. Donoso-Espinoza, “Quantum-chemical structure-activity relationships in carbamate insecticides,” Molecular Engineering, vol. 5, no. 4, pp. 391–401, 1995. View at Publisher · View at Google Scholar · View at Scopus
  52. J. S. Gómez-Jeria and L. Lagos-Arancibia, “Quantum-chemical structure-affinity studies on kynurenic acid derivatives as Gly/NMDA receptor ligands,” International Journal of Quantum Chemistry, vol. 71, no. 6, pp. 505–511, 1999. View at Google Scholar · View at Scopus
  53. J. S. Gómez-Jeria, L. A. Gerli-Candia, and S. M. Hurtado, “A structure-affinity study of the opioid binding of some 3-substituted morphinans,” Journal of the Chilean Chemical Society, vol. 49, no. 4, pp. 307–312, 2004. View at Google Scholar · View at Scopus
  54. F. Soto-Morales and J. S. Gómez-Jeria, “A theoretical study of the inhibition of wild-type and drug-resistant HTV-1 reverse transcriptase by some thiazolidenebenzenesulfonamide derivatives,” Journal of the Chilean Chemical Society, vol. 52, no. 3, pp. 1214–1219, 2007. View at Google Scholar · View at Scopus
  55. J. S. Gómez-Jeria, “A DFT study of the relationships between electronic structure and peripheral benzodiazepine receptor affinity in a group of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides,” Journal of the Chilean Chemical Society, vol. 55, no. 3, pp. 381–384, 2010, Erratum in Journal of the Chilean Chemical Society, vol. 55, no. 4, p. 9, 2010. View at Google Scholar · View at Scopus
  56. T. Bruna-Larenas and J. S. Gómez-Jeria, “A DFT and semiempirical model-based study of opioid receptor affinity and selectivity in a group of molecules with a morphine structural core,” International Journal of Medicinal Chemistry, vol. 2012, Article ID 682495, 16 pages, 2012. View at Publisher · View at Google Scholar
  57. R. F. Hudson and G. Klopman, “A general perturbation treatment of chemical reactivity,” Tetrahedron Letters, vol. 8, no. 12, pp. 1103–1108, 1967. View at Google Scholar · View at Scopus
  58. G. Klopman and R. F. Hudson, “Polyelectronic perturbation treatment of chemical reactivity,” Theoretica Chimica Acta, vol. 8, no. 2, pp. 165–174, 1967. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Klopman, “Chemical reactivity and the concept of charge- and frontier-controlled reactions,” Journal of the American Chemical Society, vol. 90, no. 2, pp. 223–234, 1968. View at Google Scholar · View at Scopus
  60. K. Fukui and H. Fujimoto, Frontier Orbitals and Reaction Paths: Selected Papers of Kenichi Fukui, World Scientific, River Edge, NJ, USA, 1997.
  61. J. S. Gómez-Jeria, Elements of Molecular Electronic Pharmacology, Ediciones Sokar, Santiago, Chile, 2013 (Spanish).
  62. D. A. Alarcón, F. Gatica-Díaz, and J. S. Gómez-Jeria, “Modeling the relationships between molecular structure and inhibition of virus-induced cytopathic effects. Anti-HIV and anti-H1N1 (Influenza) activities as examples,” Journal of the Chilean Chemical Society, vol. 58, no. 3, pp. 1651–1659, 2013. View at Google Scholar
  63. J. S. Gómez-Jeria and M. Ojeda-Vergara, “Parametrization of the orientational effects in the drug-receptor interaction,” Journal of the Chilean Chemical Society, vol. 48, no. 4, pp. 119–124, 2003. View at Google Scholar · View at Scopus
  64. J. S. Gómez-Jeria and M. Ojeda-Vergara, “Electrostatic medium effects and formal quantum structure-activity relationships in apomorphines interacting with D1 and D2 dopamine receptors,” International Journal of Quantum Chemistry, vol. 61, no. 6, pp. 997–1002, 1997. View at Google Scholar · View at Scopus
  65. C. Barahona-Urbina, S. Nuñez-Gonzalez, and J. S. Gómez-Jeria, “Model-based quantum-chemical study of the uptake of some polychlorinated pollutant compounds by Zucchini subspecies,” Journal of the Chilean Chemical Society, vol. 57, no. 4, pp. 1497–1503, 2012. View at Google Scholar
  66. M. J. Frisch, G. W. Trucks, H. B. Schlegel et al., Gaussian 98 Rev.A.11.3, Gaussian, Pittsburgh, Pa, USA, 2002.
  67. J. S. Gómez-Jeria, “An empirical way to correct some drawbacks of mulliken population analysis,” Journal of the Chilean Chemical Society, vol. 54, no. 4, pp. 482–485, 2009, Erratum in Journal of the Chilean Chemical Society, vol. 55, no. 4, p. 9, 2010. View at Google Scholar · View at Scopus
  68. StatSoft, Statistica 8.0, StatSoft, Tulsa, Okla, USA, 1984–2007.
  69. J. S. Gómez-Jeria, “Approximate molecular electrostatric potentials of protonated mescaline analogues,” Acta Sud Americana de Química, vol. 4, no. 1, pp. 1–9, 1984. View at Google Scholar
  70. J. S. Gómez-Jeria and D. Morales-Lagos, “The mode of binding of phenylalkylamines to the serotonergic receptor,” in QSAR in Design of Bioactive Drugs, M. Kuchar, Ed., pp. 145–173, Prous, Barcelona, Spain, 1984. View at Google Scholar